Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

Tesla’s first-quarter profits plunged by more than two-thirds amid a backlash against Elon Musk’s electric car company that ...

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach ...

BANGKOK — A new report published on Feb. 18 detailed widespread discrepancies in data provided from Southeast Asia’s ...

Vertex Pharmaceuticals Inc. closed 5.66% below its 52-week high of $519.88, which the company reached on November 8th.

Catalyst Pharmaceuticals Inc. closed 13.60% below its 52-week high of $26.16, which the company reached on March 24th.

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

Big pharma’s jumped into CBD sleep land with Sandoz backing Avecho; could this bring a new rush into ASX CBD stocks like Neurotech?

Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

Cycle Pharmaceuticals (Cycle) has launched Cycle Vita PKU, an AI-powered app to help patients with PKU manage every aspect of ...

Regeneron signs $3 billion deal with FUJIFILM to expand biologics manufacturing in North Carolina, boosting U.S. capacity and ...